Company Overview and News

0
Golden Deeps to start drilling at Namibian vanadium and base metals project

2018-08-09 proactiveinvestors.com.au
Golden Deeps Ltd (ASX:GED) has identified an opportunity to define near-surface vanadium, lead and zinc resources through drilling at its Grootfontein Base Metal Project in northern Namibia.
GED

0
Golden Deeps raises $2.2 million to accelerate work at Namibian vanadium-lead-zinc project

2018-05-08 proactiveinvestors.com.au
Golden Deeps Ltd. (ASX:GED) will use $2.2 million in a private placement to accelerate drilling, development and process design of the Abenab-Christiana Vanadium-Lead-Zinc Project in Namibia.
GED

115
Companies To Benefit From The Stationary Energy Storage Boom

2018-04-30 seekingalpha
Types of stationary energy storage. Hydro has historically dominated, however Li-ion battery storage is growing fast. Vanadium flow can also have a place.
RPC SRHYY OGFGY NMT EFR RDRUY AES JCI SBR LGO SCEDN GE RPCGY SCEDP CAMCF SHCAY BSWQY ENPH RNO DDAIF RED RPCGF TNG GRRLF AVL SIEGY KRC ENIC STNUF TON ENIA RES GED SYR GM UUUU ATVVF RFX PCRFY GEC LGORF NIPNF SYAAF SCE RRSSF GRR TSLA ESNC GNE ENS SNE OGFGF ORG

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...